Wet AMD
01.12.21
Notal Vision Launches First US Home OCT Longitudinal Study with Patient Self-Operated DeviceSource: Notal Vision
01.12.21
Clearside Biomedical Announces First Patients Enrolled in Phase 1/2a Clinical Trial of CLS-AX for the Treatment of Wet AMDSource: Clearside Biomedical
01.08.21
Graybug Vision Completes Treatment Phase of ALTISSIMO Trial in Wet AMD with 12-Month Topline DataSource: Graybug Vision
12.29.20
Fewer New Cases of Intraocular Inflammation After First Year of Abicipar in AMD PatientsSource: Medscape
12.23.20
Conbercept Treatment of Wet AMD Completes 36-Week Primary Endpoint Visits of Phase 3 TrialSource: Chengdu Kanghong
12.08.20
RetinAI Announces Collaboration with Novartis to Provide Artificial Intelligence Solutions in OphthalmologySource: RetinAI Medical
11.16.20
Innovent Announces the Results of the Phase 1 Clinical Trial of IBI302 for Wet AMD at AAO 2020Source: Innovent Biologics
11.16.20
Kodiak Sciences Completes Enrollment of Phase 2b/3 Pivotal Study of KSI-301 in Patients with Wet AMDSource: Kodiak Sciences
11.16.20
Adverum Biotechnologies Announces Positive Interim Data From OPTIC Phase 1 Trial of ADVM-022 Intravitreal Gene Therapy for Wet AMDSource: Adverum Biotechnologies
11.11.20
Samsung Bioepis Announces 1-year Results From Phase 3 Study of SB11 Proposed Lucentis BiosimilarSource: Samsung Bioepis